Hepatic microcirculation and mechanisms of portal hypertension

J Gracia-Sancho, G Marrone… - Nature reviews …, 2019 - nature.com
The liver microcirculatory milieu, mainly composed of liver sinusoidal endothelial cells
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …

ACVR1 function in health and disease

JA Valer, C Sánchez-de-Diego, C Pimenta-Lopes… - Cells, 2019 - mdpi.com
Activin A receptor type I (ACVR1) encodes for a bone morphogenetic protein type I receptor
of the TGFβ receptor superfamily. It is involved in a wide variety of biological processes …

Measurement of the hepatic venous pressure gradient and transjugular liver biopsy

T Reiberger, P Schwabl, M Trauner… - JoVE (Journal of …, 2020 - jove.com
Here we provide a detailed protocol describing the clinical procedure of hepatic venous
pressure gradient (HVPG) measurement in patients with advanced chronic liver disease …

Characteristics of selected antioxidative and bioactive compounds in meat and animal origin products

B Kulczyński, A Sidor, A Gramza-Michałowska - Antioxidants, 2019 - mdpi.com
Meat and meat products have a high nutritional value. Besides major components, meat is
rich in bioactive components, primarily taurine, l-carnitine, choline, alpha-lipoic acid …

[HTML][HTML] Compensated liver cirrhosis: natural course and disease-modifying strategies

R Kumar, S Kumar, SS Prakash - World Journal of Methodology, 2023 - ncbi.nlm.nih.gov
Compensated liver cirrhosis (CLC) is defined as cirrhosis with one or more decompensating
events, such as ascites, variceal haemorrhage, or hepatic encephalopathy. Patients with …

Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis

CC Tzang, WC Lin, LH Lin, TY Lin, KV Chang, WT Wu… - Nutrition journal, 2024 - Springer
Background Cardiovascular disease (CVD) remains the foremost cause of mortality globally.
Taurine, an amino acid, holds promise for cardiovascular health through mechanisms such …

Test–retest reliability and consistency of HVPG and impact on trial design: a study in 289 patients from 20 randomized controlled trials

W Bai, M Al‐Karaghouli, J Stach, S Sung… - …, 2021 - Wiley Online Library
Background and Aims Portal hypertension (PH) is a major driver for cirrhosis complications.
Portal pressure is estimated in practice by the HVPG. The assessment of HVPG changes …

[HTML][HTML] Evolution of care in cirrhosis: preventing hepatic decompensation through pharmacotherapy

S Lee, S Saffo - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Cirrhosis is a leading cause of morbidity and mortality, impacting more than 120 million
people worldwide. Although geographic differences exist, etiologic factors such as alcohol …

Pre/postnatal taurine supplementation improves neurodevelopment and brain function in mice offspring: A persistent developmental study from puberty to maturity

MM Ommati, H Rezaei, RM Socorro, W Tian, J Zhao… - Life Sciences, 2024 - Elsevier
Taurine (TAU) is a sulfur-containing amino acid abundantly found in the human body.
Endogenously, TAU is synthesized from cysteine in the liver. However, newborns rely …

Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms

K Mousavi, H Niknahad, A Ghalamfarsa… - Clinical and …, 2020 - termedia.pl
Cirrhosis-induced heart injury and cardiomyopathy is a serious consequence of this
disease. It has been shown that bile duct ligated (BDL) animals could serve as an …